Correction with blood T1 is essential when measuring post-contrast myocardial T1 value in patients with acute myocardial infarction

Journal of Cardiovascular Magnetic Resonance

Volumn 15, Issue 1, 2013, Pages

  Choi, Eui Young ^a   Hwang, Sung Ho ^b   Yoon, Young Won ^a   Park, Chul Hwan ^b   Paek, Mun Young ^c   Greiser, Andreas ^d   Chung, Hyemoon ^a   Yoon, Ji Hyun ^a   Kim, Jong Youn ^a   Min, Pil Ki ^a   Lee, Byoung Kwon ^a   Hong, Bum Kee ^a   Rim, Se Joong ^a   Kwon, Hyuck Moon ^a   Kim, Tae Hoon ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c SIEMENS Healthcare   (South Korea)

^d SIEMENS AG   (Germany)

Author keywords

Cardiovascular magnetic resonance; Myocardium; T1 mapping

Indexed keywords

GADOTERATE MEGLUMINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC MUSCLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; HEART LEFT VENTRICLE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PRIORITY JOURNAL; T1 VALUE; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; FIBROSIS; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; TIME;

ADULT; ANALYSIS OF VARIANCE; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MEGLUMINE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

MLCS; MLOWN;

EID: 84872360310     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-15-11     Document Type: Article

References (13)

1. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker Inversion Recovery (MOLLI) for highresolution T1 mapping of the heart. Magn Reson Med. 2004; 52:141-6.
2. Lles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008; 52:1574-80.
3. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, Sibley CT, Chen MY, Bandettini WP, Arai AE. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and subclinical myocardial pathology. Eur Heart J. 2012; 33:1268-78.
4. Messroghli DR, Greiser A, Fröhlich M, Dietz R, Schulz-Menger J. Optimization and validation of a fully-integrated pulse sequence for modified Look-Locker inversion-Recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging. 2007; 26:1081-6.
5. Schelbert EB, Meier CG, Meier CG, Ceyrolles WJ, Levenson JE, Ceyrolles WJ, Levenson JE, Blair AJ, Kellman P, Jones BL, Ludwig DR, Schwartzman D, Shroff SG, Wong TC. Myocardial extravascular extracellular volumefraction measurement by gadoliniumcardiovascular magnetic resonance in humans:slow infusion versus bolus. J Cardiovasc Magn Reson. 2011; 13:16.
6. Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, Arai AE, Zuehlsdorff S, Guehring J, Kellman P. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012; 67:1644-55.
7. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011; 57:89-903.
8. Messroghli DR, Plein S, Higgins DM, Walters K, Jones TR, Ridgway JP, Sivananthan MU. Human myocardium:single-breath-hold MR T1 mapping with high spatial resolutionreproducibility study. Radiology. 2006; 238:1004-12.
9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart A Statement for Healthcare Professionals From the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105:539-42.
10. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson. 2012; 14:27.
11. Jerosch-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008; 295:H1234-42.
12. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayedcontrast enhancement to irreversible injury, infarct age, and contractilefunction. Circulation. 1999; 100:1992-2002.
13. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A. I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008; 359:2456-67.